University of Groningenfounded in 1614  -  top 100 university
Close
About us How to find us prof. dr. J.L. (Hans) Hillege

prof. dr. J.L. (Hans) Hillege

Cardiology

No picture available
E-mail:
h.hillege umcg.nl

Research

Research units:

1 - 23 out of 23Page size: 50
  1. Streng, K. W. (2019). Non-cardiac comorbidities in heart failure with preserved ejection fraction: Focussing on obesity and renal dysfunction. [Groningen]: University of Groningen.
  2. Pang, C. (2018). Computational methods for data discovery, harmonization and integration: Using lexical and semantic matching with an application to biobanking phenotypes. [Groningen]: University of Groningen.
  3. Demissei, B. G. (2017). Optimizing clinical risk stratification in acute heart failure. [Groningen]: University of Groningen.
  4. Kraai, I. (2017). Patient-reported outcomes in patients with heart failure. [Groningen]: Rijksuniversiteit Groningen.
  5. Ploegstra, M-J. (2017). Prognostic factors, treatment goals and clinical endpoints in pediatric pulmonary arterial hypertension. [Groningen]: Rijksuniversiteit Groningen.
  6. Douwes, J. M. (2017). Shaping the future of paediatric pulmonary arterial hypertension. [Groningen]: Rijksuniversiteit Groningen.
  7. Cao, Q. (2016). Towards optimal decision making in personalized medicine: Potential value assessment of biomarkers in heart failure exemplars. [Groningen]: University of Groningen.
  8. Barents, M. (2015). Chronic heart failure diagnostics and application of neuropeptides in residential elderly. [Groningen]: University of Groningen.
  9. Valente, M. (2015). Diuretic response and cardiorenal interaction in heart failure. [S.l.]: [S.n.].
  10. Schroten, N. (2015). New roles for renin in heart failure and cardio-renal interaction. [S.l.]: [S.n.].
  11. Beyer, A. R-M. (2015). The human dimension in the assessment of medicines: Perception, preferences, and decision making in the European regulatory environment. [Groningen]: University of Groningen.
  12. Mahmoud, K. (2014). Symptom onset and treatment in acute myocardial infarction. [S.l.]: [S.n.].
  13. de Vries, A. E. (2013). The use of computer decision support and telemonitoring in heart failure. Groningen: [s.n.].
  14. Szymanski, M. K. (2012). Cardiorenal interaction : experimental and clinical studies. [S.n.].
  15. Valkenhoef, G. H. M. V. (2012). Making better use of clinical trials: computational decision support methods for evidence-based drug benefit-risk assessment. Groningen: s.n.
  16. Linssen, G. C. M. (2011). BNP and NT-proBNP in cardiovascular disease. Groningen: [s.n.].
  17. Veeger, N. J. G. M. (2010). Individual approach towards optimal oral anticoagulation. Groningen: s.n.
  18. Loon, R. L. E. V. (2010). Paediatric pulmonary hypertension: epidemiology, characterisation and treatment. Groningen: s.n.
  19. Damman, K. (2009). Cardiorenal interaction in heart failure. s.n.
  20. Geluk, C. A. (2008). Coronary risk stratification: from PREVEND to the prevention of coronary events. [S.l.]: [s.n.].
  21. Borggreve, S. E. (2008). The role of CETP and HDL metabolism in cardiac disease. [S.n.].
  22. Lesman-Leegte, G. A. T. (2007). Quality of life and depressive symptoms in patients with heart failure. Groningen: [S.n.].
  23. Verhave, J. C. (2004). The impact of albuminuria and cardiovascular risk factors on renal function. Groningen: s.n.

ID: 85102

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube